CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,555,489
+$3,699,694 QoQ
Shares Held
1,050,934
+3.8% QoQ
Ownership
0.836%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ARQT ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ARQT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,555,489 | 1,050,934 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,855,795 | 1,012,555 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,470,547 | 1,014,826 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,839,330 | 999,434 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,530,225 | 965,066 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,462,411 | 860,768 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $12,241,739 | 878,804 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,996,567 | 859,846 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,917,313 | 851,324 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,439,674 | 750,724 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,845,357 | 571,318 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,038,047 | 383,813 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,144,347 | 329,942 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,327,522 | 302,502 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,465,574 | 301,728 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,562,787 | 291,093 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,629,810 | 217,260 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,870,566 | 200,964 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,115,915 | 198,453 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,678,545 | 195,837 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,277,394 | 193,382 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,198,142 | 179,680 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,978,679 | 141,439 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,241,253 | 110,623 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,063,759 | 68,246 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $656,225 | 22,021 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||